Krystal Biotech, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 332.29 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.84B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Details
| Name | Krystal Biotech, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 295 |
| Founded | 2015 |
| Ipo Date | 2017-09-20 |
| Ceo | Krish Krishnan |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US5011471027 |
| Cusip | 501147102 |
| Cik | 0001711279 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Krish S. Krishnan M.B.A., M.S. | Founder, Chairman, President and Chief Executive Officer |
| Suma M. Krishnan | Founder, President of Research & Development and Director |
| Kathryn A. Romano CPA | Executive Vice President and Chief Accounting Officer |
| John C. Thomas | EVice President, General Counsel and Corporate Secretary |
| John Karakkal | Vice President of North American Sales and Marketing |
| Dr. Stephane Paquette Ph.D. | Senior Vice President of Corporate Development |
| Josh Suskin | Senior Director and Head of US Human Resources |
| Laurent Goux | Executive Vice President and Head of International |
| Dr. David Chien M.D. | Senior Vice President of Clinical Development |
| Christine Wilson | Senior Vice President and Head of US Commercial |
Contact
| Address | 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203, United States |
| Phone | 412 586 5830 |
| Website | https://www.krystalbio.com |